img

Global Angiotensin Converting Enzyme Inhibitors Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Angiotensin Converting Enzyme Inhibitors Market Insights, Forecast to 2034

Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II.
Market Analysis and InsightsGlobal Angiotensin Converting Enzyme Inhibitors Market
Global Angiotensin Converting Enzyme Inhibitors market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Angiotensin Converting Enzyme Inhibitors industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Angiotensin Converting Enzyme Inhibitors market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Angiotensin Converting Enzyme Inhibitors market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
AstraZeneca
Novartis AG
Daiichi Sankyo, Inc
Sanofi
Merck
Abbott
Segment by Type
Benazepril (Lotensin)
Captopril
Enalapril (Vasotec)
Fosinopril
Lisinopril (Prinivil, Zestril)
Moexipril
Perindopril
Quinapril (Accupril)
Ramipril (Altace)
Trandolapril

Segment by Application


Coronary Artery Disease
Heart Failure
Diabetes
Chronic Kidney Diseases
Heart Attacks
Scleroderma
Migraines
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Angiotensin Converting Enzyme Inhibitors introduction, etc. Angiotensin Converting Enzyme Inhibitors Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Angiotensin Converting Enzyme Inhibitors
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Benazepril (Lotensin)
1.2.3 Captopril
1.2.4 Enalapril (Vasotec)
1.2.5 Fosinopril
1.2.6 Lisinopril (Prinivil, Zestril)
1.2.7 Moexipril
1.2.8 Perindopril
1.2.9 Quinapril (Accupril)
1.2.10 Ramipril (Altace)
1.2.11 Trandolapril
1.3 Market by Application
1.3.1 Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Coronary Artery Disease
1.3.3 Heart Failure
1.3.4 Diabetes
1.3.5 Chronic Kidney Diseases
1.3.6 Heart Attacks
1.3.7 Scleroderma
1.3.8 Migraines
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin Converting Enzyme Inhibitors Market Perspective (2018-2033)
2.2 Global Angiotensin Converting Enzyme Inhibitors Growth Trends by Region
2.2.1 Angiotensin Converting Enzyme Inhibitors Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Angiotensin Converting Enzyme Inhibitors Historic Market Size by Region (2018-2023)
2.2.3 Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Region (2024-2033)
2.3 Angiotensin Converting Enzyme Inhibitors Market Dynamics
2.3.1 Angiotensin Converting Enzyme Inhibitors Industry Trends
2.3.2 Angiotensin Converting Enzyme Inhibitors Market Drivers
2.3.3 Angiotensin Converting Enzyme Inhibitors Market Challenges
2.3.4 Angiotensin Converting Enzyme Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Angiotensin Converting Enzyme Inhibitors by Players
3.1.1 Global Angiotensin Converting Enzyme Inhibitors Revenue by Players (2018-2023)
3.1.2 Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Players (2018-2023)
3.2 Global Angiotensin Converting Enzyme Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Angiotensin Converting Enzyme Inhibitors, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio
3.4.1 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin Converting Enzyme Inhibitors Revenue in 2022
3.5 Global Key Players of Angiotensin Converting Enzyme Inhibitors Head office and Area Served
3.6 Global Key Players of Angiotensin Converting Enzyme Inhibitors, Product and Application
3.7 Global Key Players of Angiotensin Converting Enzyme Inhibitors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Type
4.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Type (2018-2023)
4.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2024-2033)
5 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Application
5.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Application (2018-2023)
5.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
6.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type
6.2.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023)
6.2.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033)
6.2.3 North America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
6.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application
6.3.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023)
6.3.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033)
6.3.3 North America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
6.4 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country
6.4.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
6.4.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
7.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type
7.2.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023)
7.2.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033)
7.2.3 Europe Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
7.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application
7.3.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023)
7.3.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033)
7.3.3 Europe Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
7.4 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country
7.4.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
7.4.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
8.2 China Angiotensin Converting Enzyme Inhibitors Market Size by Type
8.2.1 China Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023)
8.2.2 China Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033)
8.2.3 China Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
8.3 China Angiotensin Converting Enzyme Inhibitors Market Size by Application
8.3.1 China Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023)
8.3.2 China Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033)
8.3.3 China Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
9.2 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Type
9.2.1 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023)
9.2.2 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033)
9.2.3 Asia Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
9.3 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Application
9.3.1 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023)
9.3.2 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033)
9.3.3 Asia Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
9.4 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region
9.4.1 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023)
9.4.3 Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type
10.2.1 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application
10.3.1 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country
10.4.1 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Introduction
11.1.4 Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Introduction
11.2.4 AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.2.5 AstraZeneca Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Introduction
11.3.4 Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.3.5 Novartis AG Recent Developments
11.4 Daiichi Sankyo, Inc
11.4.1 Daiichi Sankyo, Inc Company Details
11.4.2 Daiichi Sankyo, Inc Business Overview
11.4.3 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Introduction
11.4.4 Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.4.5 Daiichi Sankyo, Inc Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Angiotensin Converting Enzyme Inhibitors Introduction
11.5.4 Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.5.5 Sanofi Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Angiotensin Converting Enzyme Inhibitors Introduction
11.6.4 Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.6.5 Merck Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Angiotensin Converting Enzyme Inhibitors Introduction
11.7.4 Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.7.5 Abbott Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Benazepril (Lotensin)
Table 3. Key Players of Captopril
Table 4. Key Players of Enalapril (Vasotec)
Table 5. Key Players of Fosinopril
Table 6. Key Players of Lisinopril (Prinivil, Zestril)
Table 7. Key Players of Moexipril
Table 8. Key Players of Perindopril
Table 9. Key Players of Quinapril (Accupril)
Table 10. Key Players of Ramipril (Altace)
Table 11. Key Players of Trandolapril
Table 12. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 13. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region (2018-2023)
Table 16. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region (2024-2033)
Table 18. Angiotensin Converting Enzyme Inhibitors Market Trends
Table 19. Angiotensin Converting Enzyme Inhibitors Market Drivers
Table 20. Angiotensin Converting Enzyme Inhibitors Market Challenges
Table 21. Angiotensin Converting Enzyme Inhibitors Market Restraints
Table 22. Global Angiotensin Converting Enzyme Inhibitors Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Angiotensin Converting Enzyme Inhibitors Revenue Share by Players (2018-2023)
Table 24. Global Top Angiotensin Converting Enzyme Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2022)
Table 25. Global Angiotensin Converting Enzyme Inhibitors Industry Ranking 2021 VS 2022 VS 2023
Table 26. Global 5 Largest Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue (CR5 and HHI) & (2018-2023)
Table 27. Global Key Players of Angiotensin Converting Enzyme Inhibitors, Headquarters and Area Served
Table 28. Global Key Players of Angiotensin Converting Enzyme Inhibitors, Product and Application
Table 29. Global Key Players of Angiotensin Converting Enzyme Inhibitors, Product and Application
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2018-2023)
Table 33. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2024-2033)
Table 35. Global Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Angiotensin Converting Enzyme Inhibitors Revenue Share by Application (2018-2023)
Table 37. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Angiotensin Converting Enzyme Inhibitors Revenue Share by Application (2024-2033)
Table 39. North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 40. North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033) & (US$ Million)
Table 41. North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 42. North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033) & (US$ Million)
Table 43. North America Angiotensin Converting Enzyme Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 45. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 46. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 47. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033) & (US$ Million)
Table 48. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 49. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033) & (US$ Million)
Table 50. Europe Angiotensin Converting Enzyme Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 51. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 52. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 53. China Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 54. China Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033) & (US$ Million)
Table 55. China Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 56. China Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 58. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033) & (US$ Million)
Table 59. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 60. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033) & (US$ Million)
Table 61. Asia Angiotensin Converting Enzyme Inhibitors Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 62. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 63. Asia Angiotensin Converting Enzyme Inhibitors Market Size by Region (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2024-2033) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2024-2033) & (US$ Million)
Table 68. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 69. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 70. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Angiotensin Converting Enzyme Inhibitors Product
Table 74. Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Angiotensin Converting Enzyme Inhibitors Product
Table 79. AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 80. AstraZeneca Recent Developments
Table 81. Novartis AG Company Details
Table 82. Novartis AG Business Overview
Table 83. Novartis AG Angiotensin Converting Enzyme Inhibitors Product
Table 84. Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 85. Novartis AG Recent Developments
Table 86. Daiichi Sankyo, Inc Company Details
Table 87. Daiichi Sankyo, Inc Business Overview
Table 88. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Product
Table 89. Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 90. Daiichi Sankyo, Inc Recent Developments
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Angiotensin Converting Enzyme Inhibitors Product
Table 94. Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 95. Sanofi Recent Developments
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Angiotensin Converting Enzyme Inhibitors Product
Table 99. Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Developments
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Angiotensin Converting Enzyme Inhibitors Product
Table 104. Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 105. Abbott Recent Developments
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Angiotensin Converting Enzyme Inhibitors Market Share by Type: 2022 VS 2033
Figure 3. Benazepril (Lotensin) Features
Figure 4. Captopril Features
Figure 5. Enalapril (Vasotec) Features
Figure 6. Fosinopril Features
Figure 7. Lisinopril (Prinivil, Zestril) Features
Figure 8. Moexipril Features
Figure 9. Perindopril Features
Figure 10. Quinapril (Accupril) Features
Figure 11. Ramipril (Altace) Features
Figure 12. Trandolapril Features
Figure 13. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 14. Global Angiotensin Converting Enzyme Inhibitors Market Share by Application: 2022 VS 2033
Figure 15. Coronary Artery Disease Case Studies
Figure 16. Heart Failure Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Chronic Kidney Diseases Case Studies
Figure 19. Heart Attacks Case Studies
Figure 20. Scleroderma Case Studies
Figure 21. Migraines Case Studies
Figure 22. Others Case Studies
Figure 23. Angiotensin Converting Enzyme Inhibitors Report Years Considered
Figure 24. Global Angiotensin Converting Enzyme Inhibitors Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 25. Global Angiotensin Converting Enzyme Inhibitors Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 26. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region: 2022 VS 2033
Figure 27. Global Angiotensin Converting Enzyme Inhibitors Market Share by Players in 2022
Figure 28. Global Top Angiotensin Converting Enzyme Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2022)
Figure 29. The Top 10 and 5 Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue in 2022
Figure 30. North America Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. North America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
Figure 32. North America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
Figure 33. North America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 34. United States Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Canada Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Europe Angiotensin Converting Enzyme Inhibitors Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
Figure 38. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
Figure 39. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 40. Germany Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. France Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. U.K. Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Italy Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Russia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Angiotensin Converting Enzyme Inhibitors Market Size YoY (2018-2033) & (US$ Million)
Figure 47. China Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
Figure 48. China Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
Figure 49. Asia Angiotensin Converting Enzyme Inhibitors Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Asia Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
Figure 51. Asia Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
Figure 52. Asia Angiotensin Converting Enzyme Inhibitors Market Share by Region (2018-2033)
Figure 53. Japan Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. South Korea Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. China Taiwan Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Southeast Asia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. India Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Australia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Size YoY (2018-2033) & (US$ Million)
Figure 60. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2018-2033)
Figure 61. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2018-2033)
Figure 62. Middle East, Africa, and Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 63. Brazil Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 64. Mexico Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 65. Turkey Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 66. Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 67. Israel Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 68. GCC Countries Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 69. Pfizer Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 70. AstraZeneca Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 71. Novartis AG Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 72. Daiichi Sankyo, Inc Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 73. Sanofi Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 74. Merck Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 75. Abbott Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries